Lument Finance Trust, Inc. (NYSE:LFT) Q3 2023 Earnings Call Transcript
Operator: Good morning and thank you for joining the Lument Finance Trust Third Quarter 2023 Earnings Call.
Posts Tagged ‘James Flynn’
Lument Finance Trust, Inc. (NYSE:LFT) Q4 2022 Earnings Call Transcript
Operator: Good morning and thank you for joining the Lument Finance Trust Fourth Quarter 2022 Earnings Call.
Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares
According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E.
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...
Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)
James Flynn's Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing a public equity portfolio valued...
Horizon Pharma PLC (HZNP), Apple Inc. (AAPL): How Billionaire Mark Kingdon’s Picks Performed in Q1
Kingdon Capital Management, a New-York based hedge fund, was founded by Mark E. Kingdon in 1983. Prior to this, he worked for AT&T and Century Capital Associates.
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Alcobra Ltd (ADHD): Broadfin Capital and Deerfield Initiate Passive Stakes Following Public Offering
Kevin Kotler's Broadfin Capital and James Flynn's Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD).
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves
In two new filings, Thomas E. Claugus' GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG).
Loxo Oncology Inc (LOXO): Deerfield Management Discloses 13.65% Activist Stake
Samuel Isaly's Orbimed Advisors has disclosed holding a stake in Loxo Oncology Inc (NASDAQ:LOXO).
James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)
James E. Flynn, the manager of Deerfield Management, is still bullish on Streamline Health Solutions Inc. (NASDAQ:STRM).
James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)
James E. Flynn, the manager of Deerfield Management, is bullish on Alphatec Holdings Inc (NASDAQ:ATEC).
Deerfield Management Reports Holding 6.38% of MEI Pharma
In a new 13G filing, James E. Flynn and his fund Deerfield Management reported a position in MEI Pharma Inc (NASDAQ:MEIP), which represents 6.38% of the company.
Hedge Fund News: Marc Faber, Carl Icahn, BlackRock
America’s central bank, the Federal Reserve, will eventually destroy the world economy, says respected Swiss investor Marc Faber.
